Close Menu

NEW YORK – NanoString Technologies on Sunday reported preliminary fourth quarter product and service revenue growth of 6 percent.

For the quarter ended Dec. 31, 2020, NanoString estimated product and service revenues of $35.7 million, including nCounter revenues of $23.5 million and $12.2 million in GeoMx digital spatial profiler revenues.

The nCounter instrument installed base grew to approximately 950 systems by the end of the quarter, while the GeoMx installed base grew to approximately 130 systems.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.